Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis

NCT03343639

Conditions
Pathological Conditions, Signs and Symptoms, Pruritus, Psoriasis, +5 more
Locations
  • Study Site 221 Bryant, Arkansas, United States
  • Study Site 220 Beverly Hills, California, United States
  • Study Site 204 Fremont, California, United States
  • Study Site 356 San Diego, California, United States
View all 39 locations
View Trial Details
Completed

A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

NCT02196324

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +11 more
Locations
  • Study Site 08 Bonn, Germany
  • Study Site 06 Dresden, Germany
  • Study Site 12 Düsseldorf, Germany
  • Study Site 02 Frankfurt, Germany
View all 15 locations
View Trial Details
Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis

NCT03922607

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Total Skin and Beauty Derm Ctr /ID# 222593 Birmingham, Alabama, United States
  • Alliance Dermatology and MOHs /ID# 222622 Phoenix, Arizona, United States
  • Anaheim Clinical Trials LLC /ID# 213645 Anaheim, California, United States
  • Dermatology Res. Assoc., CA /ID# 224980 Los Angeles, California, United States
View Trial Details
Completed

A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

NCT03875508

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Advanced Research Associates /ID# 210634 Glendale, Arizona, United States
  • Cognitive Clinical Trials /ID# 210770 Scottsdale, Arizona, United States
  • Burke Pharmaceutical Research /ID# 211386 Hot Springs, Arkansas, United States
  • Bakersfield Derma & Skin Cance /ID# 210773 Bakersfield, California, United States
View all 26 locations
View Trial Details
Completed

Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site

NCT02771210

Conditions
Ankylosis, Arthritis, Arthritis, Psoriatic, +14 more
Locations
  • Novartis Investigative Site Plovdiv, Bulgaria
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Stara Zagora, Bulgaria
View all 55 locations
View Trial Details
Completed

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

NCT03535194

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
  • David Stoll, M.D. Beverly Hills, California, United States
  • California Dermatology and Clinical Research Institute Encinitas, California, United States
View all 178 locations
View Trial Details

Related conditions